Wells Fargo’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63 | Hold |
50
| – | – | ﹤0.01% | 6561 |
|
|
2025
Q4 | $61 | Hold |
50
| – | – | ﹤0.01% | 6487 |
|
|
2025
Q3 | $74 | Sell |
50
-2,279
| -98% | -$3.48K | ﹤0.01% | 6424 |
|
|
2025
Q2 | $2.7K | Sell |
2,329
-33,122
| -93% | -$46.8K | ﹤0.01% | 6174 |
|
|
2025
Q1 | $47.9K | Sell |
35,451
-50,429
| -59% | -$306K | ﹤0.01% | 5420 |
|
|
2024
Q4 | $1.13M | Sell |
85,880
-7,352
| -8% | -$100K | ﹤0.01% | 3619 |
|
|
2024
Q3 | $1.05M | Buy |
93,232
+13,006
| +16% | +$163K | ﹤0.01% | 3520 |
|
|
2024
Q2 | $862K | Buy |
80,226
+8,876
| +12% | +$114K | ﹤0.01% | 3581 |
|
|
2024
Q1 | $1.06M | Buy |
71,350
+2,180
| +3% | +$36K | ﹤0.01% | 3418 |
|
|
2023
Q4 | $1.25M | Buy |
69,170
+51,468
| +291% | +$783K | ﹤0.01% | 3276 |
|
|
2023
Q3 | $307K | Sell |
17,702
-6,934
| -28% | -$120K | ﹤0.01% | 4080 |
|
|
2023
Q2 | $446K | Buy |
24,636
+23,294
| +1,736% | +$551K | ﹤0.01% | 4033 |
|
|
2023
Q1 | $35.7K | Buy |
1,342
+1,113
| +486% | +$31.7K | ﹤0.01% | 5346 |
|
|
2022
Q4 | $4.43K | Sell |
229
-204
| -47% | -$4.26K | ﹤0.01% | 5811 |
|
|
2022
Q3 | $9K | Buy |
433
+75
| +21% | +$1.44K | ﹤0.01% | 5732 |
|
|
2022
Q2 | $3K | Sell |
358
-1,857
| -84% | -$11.9K | ﹤0.01% | 6208 |
|
|
2022
Q1 | $15K | Sell |
2,215
-8,503
| -79% | -$86.8K | ﹤0.01% | 6126 |
|
|
2021
Q4 | $145K | Buy |
10,718
+10,508
| +5,004% | +$167K | ﹤0.01% | 5444 |
|
|
2021
Q3 | $4K | Sell |
210
-41,536
| -99% | -$882K | ﹤0.01% | 6448 |
|
|
2021
Q2 | $1.22M | Buy |
41,746
+10,694
| +34% | +$333K | ﹤0.01% | 4077 |
|
|
2021
Q1 | $1.22M | Buy |
31,052
+15,350
| +98% | +$498K | ﹤0.01% | 4106 |
|
|
2020
Q4 | $357K | Buy |
15,702
+7,660
| +95% | +$192K | ﹤0.01% | 4766 |
|
|
2020
Q3 | $182K | Buy |
+8,042
| New | +$201K | ﹤0.01% | 5007 |
|
Other funds holding PLRX
TCM
BOCH
ACM
VCM
MAM
PM